Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Amber Yates, MD
Healthcare Provider Associate Director
Pediatric Hematology-Oncology Fellowship Program
Texas Children's Hospital
6701 Fannin Street
Suite 1580
Houston, Texas, United States
Dr. Amber Yates is an Associate Director of the Pediatric Hematology-Oncology Fellowship Program. She is also Co-Director of the Sickle Cell Program, a member of the Hematology Center and Associate Professor Of Pediatrics at Baylor College of Medicine.
Her primary clinical interest is in the care of children with sickle cell disease and other hemoglobin disorders. She is particularly interested in the role of hydroxyurea therapy in improving the lives of children with sickle cell disease, as well as the long term safety and efficacy of hydroxyurea. Her other clinical interests include: hemoglobinopathies and hemolytic anemia.
Dr. Amber Yates is also interested in assisting teenage patients with hematologic disorders so they can achieve a successful transition to adult care.
Representative Publications:
Hydroxyurea treatment of children with hemoglobin SC disease
Related Content
-
Raymona Lawrence, DPHDr. Raymona Lawrence serves as the Direc...
-
GBT launches ACCEL grants program to improve access to care for people with Sickle cell diseaseGlobal Blood Therapeutics, Inc. (GBT) to...
-
FDA Approves Novel Treatment to Target Abnormality in Sickle Cell DiseaseToday, the U.S. Food and Drug Administra...
-
Jane A. Little, MDJane Little, MD, is a Professor of Medic...
-
Factors influencing utilization of hospital services by adult sickle cell disease patients: a systematic reviewBACKGROUND: Painful vaso-occlusive crisi...
-
MARAC Statement: Health Insurance Coverage for Hematopoietic Stem Cell Transplant for Sickle Cell Disease from HLA-m...Hematopoietic stem cell transplant for s...
-
Webinar Series: Sickle Cell Science: Path to Progress – Genetic Therapies in Sickle Cell DiseaseTo commemorate Sickle Cell Awareness Mon...